TKTL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. TKTL Gen Silencer sind erhältlich als TKTL CRISPR/Cas9 Knockout Plasmide und TKTL Double Nickase Plasmide. TKTL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
TKTL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TKTL1 CRISPR/Cas9 KO Plasmid (h) | sc-411134 | h | Gene Knockout | GFP | 0 | ||
TKTL1 HDR Plasmid (h) | sc-411134-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TKTL1 Double Nickase Plasmid (h) | sc-411134-NIC | h | Gene Knockout | Puromycin | 0 | ||
TKTL1 Double Nickase Plasmid (h2) | sc-411134-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TKTL1 CRISPR/Cas9 KO Plasmid (m) | sc-429917 | m | Gene Knockout | GFP | 0 | ||
TKTL1 HDR Plasmid (m) | sc-429917-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TKTL1 Double Nickase Plasmid (m) | sc-429917-NIC | m | Gene Knockout | Puromycin | 0 | ||
TKTL1 Double Nickase Plasmid (m2) | sc-429917-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TKTL2 CRISPR/Cas9 KO Plasmid (h) | sc-413546 | h | Gene Knockout | GFP | 0 | ||
TKTL2 HDR Plasmid (h) | sc-413546-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TKTL2 Double Nickase Plasmid (h) | sc-413546-NIC | h | Gene Knockout | Puromycin | 0 | ||
TKTL2 Double Nickase Plasmid (h2) | sc-413546-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TKTL2 CRISPR/Cas9 KO Plasmid (m) | sc-428878 | m | Gene Knockout | GFP | 0 | ||
TKTL2 HDR Plasmid (m) | sc-428878-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TKTL2 Double Nickase Plasmid (m) | sc-428878-NIC | m | Gene Knockout | Puromycin | 0 | ||
TKTL2 Double Nickase Plasmid (m2) | sc-428878-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TKTL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TKTL1 CRISPR Activation Plasmid (h) | sc-411134-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 CRISPR Activation Plasmid (h2) | sc-411134-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 Lentiviral Activation Particles (h) | sc-411134-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 Lentiviral Activation Particles (h2) | sc-411134-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 CRISPR Activation Plasmid (m) | sc-429917-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 CRISPR Activation Plasmid (m2) | sc-429917-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 Lentiviral Activation Particles (m) | sc-429917-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL1 Lentiviral Activation Particles (m2) | sc-429917-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 CRISPR Activation Plasmid (h) | sc-413546-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 CRISPR Activation Plasmid (h2) | sc-413546-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 Lentiviral Activation Particles (h) | sc-413546-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 Lentiviral Activation Particles (h2) | sc-413546-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 CRISPR Activation Plasmid (m) | sc-428878-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 CRISPR Activation Plasmid (m2) | sc-428878-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 Lentiviral Activation Particles (m) | sc-428878-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TKTL2 Lentiviral Activation Particles (m2) | sc-428878-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |